Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
levosimendan (1 trial)
Cardiac Output, Low (Phase 3)
Trials (1 total)
Trial APIs (1 total)